Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.77%
SPX
+0.83%
IXIC
+1.02%
FTSE
0.00%
N225
+0.06%
AXJO
+0.08%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

GSK has been in the news 321% more than usual

Feb 11, 2025, 5:31 PM
7.64%
What does GSK do
It seems that there is no content provided for summarization. Please provide the text you'd like summarized, and I'll be happy to help!
GSK has been in the news recently: Glancy Prongay & Murray LLP and Levi & Korsinsky, LLP have filed class action lawsuits against GSK PLC on behalf of investors who purchased ADRs between February 5, 2020, and August 14, 2022, alleging securities fraud and misleading information about liability risks associated with Zantac. The lawsuits could potentially expose GSK to liabilities totaling $10 billion.
📡️ Health Care
In The News

More Signals

Feature in Progress
This section is under development. Check back soon for updates!